First, data and digital business services company, has been recognised as a Major Contender in Everest Group’s Life Sciences Digital Services PEAK Matrix® Assessment 2025. This recognition reflects ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

OpenAI-backed start-up Chai Discovery has raised $70mn, valuing the group at about $550mn, as investors bet on the potential for artificial intelligence to speed up drug discovery and tackle disease.

In this week’s edition of InnovationRx, we look at a biotech entrepreneur treating a rare genetic disease, new tech aimed at ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

Hepatocellular carcinoma remains a substantial global public health concern, disproportionately affecting low-income and middle-income countries, particularly in Africa.1 Its burden in Africa is ...

A new drug that skips neurons and targets support cells cut weight and improved insulin response in lab animals, without ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

Today’s Forbes CFO newsletter focuses on Aradhana Sarin’s journey from treating patients to becoming what she calls a ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive surprises than negative ones.